‘Female Viagra' to Treat Low Libido Gets Go-Ahead From FDA Panel

‘Female Viagra' to treat low libido gets go-ahead from FDA panel

Read more: Click here to read the original, longer version of this story . A drug to boost female libido is on the cusp of approval in the US (Image: Allen Breed/PA) A BIT of a let-down? The first drug for treating low sexual desire in women is poised to go on sale in the …

Pharmalittle: We're reading about a FDA offer on drug reviews, a Moderna Covid approval, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to catch up on our reading, promenade with the official mascots, and hang around a festival. We also hope to hold still another listening party, where the rotation will include this, this, this, this, and this. And what about you? This is a…

FDA Offers to Trade Faster Drug Reviews for Lower US Prices

Food and Drug Administration Commissioner Marty Makary said his agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the US and other countries, an unusual proposition from the regulator that’s long avoided contentious pricing debates.

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually determined after an approval in the U.S.

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says – DG Verifications & Stats

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday.  The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are supporting “U.S. national interests.” But previous announcements on the voucher program did not expl…

FDA's Makary calls for tying fast-review vouchers to lower US prices, without specifics

FDA Commissioner Marty Makary is calling for a seemingly unprecedented idea of dangling the promise of speedy reviews for experimental medicines in exchange for drugmakers vowing to lower US drug prices. The idea, floated by ...